Supporting digital medical devices from incubation to market access
The digitalisation of the healthcare sector has a great potential to provide benefits for patients and healthcare providers, both now and in the future. However, successfully launching digital medical devices on the European market is a complex process. Luxinnovation, EIT Health and Medical Valley are inviting healthtech stakeholders to exchange experience on how national and regional healthtech hubs in Europe can optimise their support to digital medical device companies all the way from incubation and R&D activities to market launch.
Digital medical devices (DMDs) are a cornerstone of the digitalisation of the healthcare sector. Ensuring that high-potential devices succeed with the journey from initial concept to commercialised product is a priority, but a process fraught with challenges, not least due to the complex regulatory environment. Although the European regulation on medical devices has now been clearly defined, several other key components are needed for these technologies to reach the market.
The aim of the European Digital HealthTech Hub Conference is to share best practices on how European, national and regional healthtech hubs can optimise their support to digital medical device companies all the way from early incubation to market launch. It will, in particular, focus on funding proofs of value, designing successful business models and acceleration programmes and optimising clinical trial design and endpoints.
Healthtech hubs that play a central role in creating and supporting sustainable digital health ecosystems in their regions and countries, healthtech start-ups from Europe and beyond, experts and key opinion leaders in the healthtech sector are warmly invited to join the conference.
